Trials / Completed
CompletedNCT03414463
Training to Reconnect With Emotional Awareness Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To decrease emotional self-awareness deficits and improve emotional self-regulation, particularly anxiety, anger, depression, and positive affect, through the treatment of alexithymia.
Detailed description
Phase II randomized, Waitlist Control (WLC) trial with 3-month follow-up to further establish proof of concept and early efficacy of TREAT (1:1 alexithymia treatment) for post-TBI alexithymia. It is anticipated that our target sample size is 44. The purpose of this study is to examine differences in post-treatment self-reported alexithymia and emotional self-awareness in participants with TBI randomized to TREAT or WLC. In addition to examining the differences in post-treatment self-reported emotion regulation (general), anxiety, anger, depression, positive affect (PA), global emotional function and quality of life in participants with TBI randomized to TREAT or WLC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | TREAT | A 4-week one-to-one intervention between the clinical RA (cRA) and participant. Comprised of eight sessions, it involves psycho-educational lessons and skill-building exercises to achieve objectives based on the characteristics of alexithymia. |
Timeline
- Start date
- 2018-05-08
- Primary completion
- 2023-11-10
- Completion
- 2023-11-14
- First posted
- 2018-01-30
- Last updated
- 2024-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03414463. Inclusion in this directory is not an endorsement.